Lenacapavir
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 344 publications
Rollout of lenacapavir begins in South Africa.
Journal: The Lancet. Infectious diseases
Published: June 18, 2026
A precautionary tale of lenacapavir drug-drug interactions: A case series of two persons living with HIV receiving long-acting injections.
Journal: International journal of STD & AIDS
Published: June 18, 2026
A French national observatory of people with HIV initiating lenacapavir-based treatment after regulatory approval.
Journal: Antimicrobial agents and chemotherapy
Published: June 10, 2026
People with HIV Continuing on Complex Regimens in the Era of Treatment Optimization: Characteristics and Outcomes.
Journal: AIDS patient care and STDs
Published: June 05, 2026
Injectable long-acting pre-exposure prophylaxis for HIV prevention: advancements and future directions in pharmacotherapy.
Journal: Expert opinion on pharmacotherapy
Published: June 04, 2026
CROI 2026: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases.
Journal: Topics in antiviral medicine
Published: May 13, 2026
CROI 2026: Antiretroviral THerapy in Adult, Maternal, and Pediatric Populations With HIV.
Journal: Topics in antiviral medicine
Published: May 13, 2026
Effectiveness and Safety of Lenacapavir-Containing Regimens in Highly Experienced HIV-Infected Patients With Multidrug Resistance: Real-world Results From the French Compassionate Use Program a.
Journal: Open forum infectious diseases
Published: April 29, 2026
Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure Prophylaxis.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 23, 2026
Last Updated: 06/30/2026